Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with often fatal outcomes. But what if the key to stopping this deadly progression lies in our genes?

Dr. Nima Sharifi, scientific director of the Desai Sethi Urology Institute, discovered a specific genetic variant that enables tumors to bypass treatments, effectively producing their own hormones to fuel cancer growth.

Tune in!

Dr. David Davis, is breaking new ground in understanding how toxins, especially microplastics, may contribute to neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's.

In this episode of Inside U Miami Medicine, Dr. Davis shares his journey and the groundbreaking methodologies he developed to detect and study these toxins. From cyanobacterial blooms to airborne plastic particles,

We’re exploring visionary breakthroughs in the field of

Tune in to hear more about this fascinating venture, as well as other breakthroughs and challenges in the field that are providing new avenues for disease modeling, drug screening and cellular therapies.

Dr. Helen Bermudez, a gastroenterology fellow, overcame immense challenges to pursue her dream. Born in Cuba, she immigrated to the U.S. at age 15. She spoke no English but carried an unwavering dedication to help others through medicine. Tune in as we explore Dr. Bermudez’s story of resilience and the advice she offers others facing similar paths.

Dr. Ashish Shah, a neurosurgeon and brain cancer researcher at Sylvester Comprehensive Cancer Center, is weaponizing viruses to make brain cancer cells more susceptible to chemotherapy and radiation. It’s a delicate process that involves delivering viral-based gene therapy directly into the tumor or tumor cavity to alter the fundamental genome of the cancer cells.

Tune in to learn how this treatment is offering new hope for

When the very treatment keeping a patient alive also exacts a heavy toll on lives, researchers are compelled to ask, “Is there another way?”

Glioblastoma is a brutal brain cancer. It is aggressive, common and nearly always fatal. Standard treatments of radiation and chemotherapy often leave patients with cognitive problems and a diminished quality of life.

But Dr. Macarena de la Fuente, chief of the Neuro oncology Division at Sylvester Comprehensive Cancer Center, envisions a future that empowers patients to manage tumors with fewer compromises. She investigates new drugs that prolong progression-free survival and delay the need for toxic treatments.

In some of the clinical trials she and her team are advancing, the tumors even shrank in size.

In the vast landscape of medical research, few areas are as

Dr. Dietrich, scientific director of the Miami Project to Cure Paralysis, recently joined the Inside U Miami Medicine podcast to share the latest neuroscience discoveries and how novel therapies –

Tune in.

When disaster occurs, Dr. Elizabeth Greig runs toward the chaos. She and her team follow in the wake of hurricanes, earthquakes and other hazardous events to help the world’s most vulnerable communities heal and rebuild. They provide medical care and essential resources, bolster infrastructure and strengthen the health sector. Sometimes, they construct buildings. As of April 2024, a hospital they helped erect in Port-au-Prince, Haiti, is still functioning despite the current gang violence.

Tune in to hear her talk all things disaster response, crisis

Raymond Schinazi, Ph.D., a world-renowned scientist, knows that research requires resilience. “I have file cabinets full of rejections,” he said.

In the second part of our episode with Dr. Schinazi, we explore how he developed a life-saving cure for Hepatitis C, despite being denied funding from the NIH. Instead of giving up and focusing on other antivirals, he founded his own biotech company and set his sights on revolutionizing the treatment landscape for Hepatitis C.

We’re talking to one of the most remarkable scientists of our time, Raymond Schinazi, Ph.D. Dr. Schinazi is a visionary researcher whose contributions have revolutionized the landscape of antiviral therapy. More than 94% of HIV-infected individuals in the U.S. on combination therapy take at least one of the drugs he created. He also invented the cure for Hepatitis C.

But his story begins far from the laboratories and lecture halls of prestigious universities. Growing up in Egypt during the Nasser regime, young Raymond witnessed firsthand the devastation of disease when his mother fell critically ill. Determined to make a difference, he embarked on a mission to find cures for the most challenging medical conditions.

In the first part of this captivating episode, we’re delving into Dr. Schinazi’s remarkable life story, exploring the triumphs and challenges that shaped his extraordinary career.